Literature DB >> 14669755

Acute bacterial meningitis: time for a better outcome.

Werner Zimmerli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14669755     DOI： 10.1007/s00134-003-1934-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

1.  Acute bacterial meningitis in adults. A 20-year overview.

Authors:  B Sigurdardóttir; O M Björnsson; K E Jónsdóttir; H Erlendsdóttir; S Gudmundsson
Journal:  Arch Intern Med       Date:  1997-02-24

2.  Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972.

Authors:  M Finland; M W Barnes
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

3.  Dexamethasone in adults with bacterial meningitis.

Authors:  Jan de Gans; Diederik van de Beek
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

4.  Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.

Authors:  S L Leib; J M Clements; R L Lindberg; C Heimgartner; J M Loeffler; L A Pfister; M G Täuber; D Leppert
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

Review 5.  Acute bacterial meningitis in adults. A 12-year review.

Authors:  A S Hussein; S D Shafran
Journal:  Medicine (Baltimore)       Date:  2000-11       Impact factor: 1.889

Review 6.  Current concepts in the role of the host response in Neisseria meningitidis septic shock.

Authors:  Petter Brandtzaeg; Marcel van Deuren
Journal:  Curr Opin Infect Dis       Date:  2002-06       Impact factor: 4.915

Review 7.  Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae.

Authors:  Damian N Meli; Stephan Christen; Stephen L Leib; Martin G Täuber
Journal:  Curr Opin Infect Dis       Date:  2002-06       Impact factor: 4.915

8.  Bacterial meningitis in the United States in 1995. Active Surveillance Team.

Authors:  A Schuchat; K Robinson; J D Wenger; L H Harrison; M Farley; A L Reingold; L Lefkowitz; B A Perkins
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

9.  Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study.

Authors:  W F Schlech; J I Ward; J D Band; A Hightower; D W Fraser; C V Broome
Journal:  JAMA       Date:  1985 Mar 22-29       Impact factor: 56.272

10.  Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation.

Authors:  Hakim Echchannaoui; Karl Frei; Christian Schnell; Stephen L Leib; Werner Zimmerli; Regine Landmann
Journal:  J Infect Dis       Date:  2002-08-16       Impact factor: 5.226
View more
  5 in total

Review 1.  Year in review in Intensive Care Medicine-2003. Part 1: Respiratory failure, infection and sepsis.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoît Vallet
Journal:  Intensive Care Med       Date:  2004-05-15       Impact factor: 17.440

2.  Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach.

Authors:  François G Brivet; Sophie Ducuing; Frédéric Jacobs; Isabelle Chary; Roger Pompier; Dominique Prat; Bogdan D Grigoriu; Patrice Nordmann
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

3.  Bedside evaluation of cerebral energy metabolism in severe community-acquired bacterial meningitis.

Authors:  Frantz R Poulsen; Mette Schulz; Anne Jacobsen; Åse B Andersen; Lykke Larsen; Wilhelm Schalén; Troels H Nielsen; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

4.  Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.

Authors:  Jean-Louis Vincent; Simon Nadel; Demetrios J Kutsogiannis; R T Noel Gibney; S Betty Yan; Virginia L Wyss; Joan E Bailey; Carol L Mitchell; Samiha Sarwat; Stephen M Shinall; Jonathan M Janes
Journal:  Crit Care       Date:  2005-05-17       Impact factor: 9.097

5.  Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases.

Authors:  Michael Pedersen; Thomas L Benfield; Peter Skinhoej; Allan G Jensen
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.